At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
In Brief
A Phase 1 clinical trial evaluating Convection-Enhanced Delivery and Topotecan for Brain Neoplasms, Primary Malignant. Completed, enrolled 16 participants across 1 site.
Detailed Summary
This study will evaluate the safety and efficacy of a chemotherapeutic drug (topotecan) as it is given directly into brain tumors by a delivery technique called convection-enhanced delivery. This drug has been used for different types of cancer, but in this study it will be given by an experimental delivery technique designed to maximize the amount of drug delivered to the brain tumor and minimize the side effects in other parts of the body. This study will also evaluate advanced magnetic resonance (MR) imaging techniques. The study will assess quality of life parameters throughout the follow-up period.
Study Details
Timeline
Interventions
microinfusion pumps to deliver chemotherapy directly into brain tumors
chemotherapeutic drug for the treatment of brain tumors